FDA Alerts U.S. Residents To British Recall Of Counterfeit Lipitor
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. residents may have received the counterfeit statin if they purchased drugs online, from storefront operations that supply unapproved drugs, or through state-run drug importation programs, FDA warns.
You may also be interested in...
Pfizer Expands Color-Shifting Labels Beyond Viagra To Celebrex, Lipitor
Pfizer is expanding its use of color-shifting labels beyond Viagra to five other products as part of its anti-counterfeiting efforts.
Lilly's Tirzepatide Shows Up Novo's Ozempic In Head-To-Head Diabetes Trial
The dual GLP-1/GIP agonist outpaced Novo's blockbuster GLP-1 analogue at all three doses, including the important low dose, on A1C reduction and weight reduction in patients with type 2 diabetes.
Sanofi Paid $14.6bn In Rebates In 2020; Net Prices Were Down
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: